Healthcare


 Novo Nordisk’s Wegovy approved by MHRA in the UK for cardiovascular prevention

Novo Nordisk’s Wegovy approved by MHRA in the UK for cardiovascular...

July 23, 2024 10:26 AM PDT | By Invezz

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s weight loss drug, Wegovy, for the preventi...

 Novartis (SWX: NOVN) Reports Robust Q2 Growth, Raises FY 2024 Guidance

Novartis (SWX: NOVN) Reports Robust Q2 Growth, Raises FY 2024 Guidan...

July 18, 2024 11:07 PM PDT | By Team Kalkine Media

Novartis (SWX: NOVN) has delivered strong financial results in the second quarter of 2024, leading to a raised full-year bottom-line guidance. The com...

 GE HealthCare (Nasdaq: GEHC) Expands AI Capabilities with Intelligent Ultrasound Acquisition

GE HealthCare (Nasdaq: GEHC) Expands AI Capabilities with Intelligen...

July 18, 2024 01:47 AM PDT | By Team Kalkine Media

GE Healthcare (Nasdaq: GEHC) has announced a strategic acquisition aimed at bolstering its capabilities in clinical artificial intelligence (AI) softw...

 UnitedHealth Group (NYSE: UNH) Reports Strong Second Quarter 2024 Results Amid Growth and Challenges

UnitedHealth Group (NYSE: UNH) Reports Strong Second Quarter 2024 Re...

July 16, 2024 10:05 PM PDT | By Team Kalkine Media

UnitedHealth Group (,NYSE: UNH,) has announced its second quarter 2024 financial results, demonstrating robust performance driven by significant growt...

 UnitedHealth Q2 profit beats expectations amid recovery from tech unit hack

UnitedHealth Q2 profit beats expectations amid recovery from tech un...

July 16, 2024 06:12 AM PDT | By Invezz

UnitedHealth Group (NYSE: UNH) announced a stronger-than-anticipated second-quarter profit on Tuesday, driven by robust performance in its healthcare...

 Mainz Biomed N.V. (NASDAQ: MYNZ), Pursues Breakthrough Device Designation for Next-Generation Colorectal Cancer Test

Mainz Biomed N.V. (NASDAQ: MYNZ), Pursues Breakthrough Device Design...

July 09, 2024 02:01 AM PDT | By Team Kalkine Media

Mainz Biomed N.V. (,NASDAQ: MYNZ,), a frontrunner in molecular genetics diagnostics with a focus on early cancer detection, has reached a pivotal mile...

 Grifols Founding Family and Brookfield team up for potential €5.5B takeover bid

Grifols Founding Family and Brookfield team up for potential €5.5B t...

July 08, 2024 05:20 AM PDT | By Invezz

The Grifols founding family and Canadian alternative asset manager Brookfield have joined forces to launch a potential takeover bid for Spanish pharma...

 Mediwound stock soars 60% on takeover interest

Mediwound stock soars 60% on takeover interest

July 05, 2024 07:27 AM PDT | By Invezz

Mediwound Ltd (NASDAQ: MDWD) rallied a whopping 60% on Friday following a report that Solventum Corp (NYSE: SOLV) is interested in buying the biopharm...

 Novo Nordisk reprimanded by UK for failing to disclose £7.9 M in payments

Novo Nordisk reprimanded by UK for failing to disclose £7.9 M in pay...

July 05, 2024 06:38 AM PDT | By Invezz

In an industry where transparency is paramount, Novo Nordisk, the Danish pharmaceutical giant known for its diabetes drug Ozempic and weight-loss trea...

 Well Health stock price rare pattern points to more upside

Well Health stock price rare pattern points to more upside

July 04, 2024 12:28 PM PDT | By Invezz

The Well Health Technologies (TSX: WELL) stock price has done well in the past few weeks, making it one of the best-performing companies in Canada rec...

 Bad news for Novo Nordisk weight-loss drug Wegovy

Bad news for Novo Nordisk weight-loss drug Wegovy

July 04, 2024 05:57 AM PDT | By Invezz

Novo Nordisk A/S (CPH: NOVO-B) is in the green today even though a Harvard study said its weight loss drug may increase the risk of nonarteritic anter...

 How much could the Alzheimer’s drug add to Eli Lilly’s revenue?

How much could the Alzheimer’s drug add to Eli Lilly’s revenue?

July 03, 2024 12:11 PM PDT | By Invezz

The new Alzheimer’s drug is unlikely to benefit shares of Eli Lilly & Co (NYSE: LLY) as quickly as its weight-loss drug, says Evan Seigerman. He’s...

 Eli Lilly receives FDA approval for its Alzheimer’s drug Kisunla

Eli Lilly receives FDA approval for its Alzheimer’s drug Kisunla

July 02, 2024 11:59 AM PDT | By Invezz

Eli Lilly & Co (NYSE: LLY) received approval for its Alzheimer’s drug from the Food & Drug Administration on Tuesday.  The development is...

 CVS Health stock price analysis as Walgreens implodes

CVS Health stock price analysis as Walgreens implodes

June 27, 2024 06:02 PM PDT | By Invezz

CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 202...

 GSK’s (LSE/NYSE: GSK) Omjjara Approved in Japan for Myelofibrosis Treatment

GSK’s (LSE/NYSE: GSK) Omjjara Approved in Japan for Myelofibrosis Tr...

June 27, 2024 02:24 AM PDT | By Team Kalkine Media

GSK plc (LSE/,NYSE: GSK,) has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Omjjara (momelotinib) for the treatmen...

 Zealand Pharma stock rallies 20%: what happened?

Zealand Pharma stock rallies 20%: what happened?

June 21, 2024 06:55 AM PDT | By Invezz

Zealand Pharma (CPH: ZEAL) rallied more than 20% this morning after reporting positive results from an early stage trial of its new weight loss treatm...

 Why has the Sarepta stock price (SRPT) gone up more than 35%?

Why has the Sarepta stock price (SRPT) gone up more than 35%?

June 21, 2024 02:12 AM PDT | By Invezz

Sarepta Therapeutics (NASDAQ: SRPT), a pharmaceutical company that describes itself as specializing in “precision genetic medicine for rare diseases”,...

 Evotec (NASDAQ: EVO) and Bristol Myers Squibb: Advancing Neuroscience Innovation

Evotec (NASDAQ: EVO) and Bristol Myers Squibb: Advancing Neuroscienc...

June 12, 2024 01:12 AM PDT | By Team Kalkine Media

Evotec SE (,NASDAQ: EVO,) has announced a significant leap forward in its neuroscience collaboration with Bristol Myers Squibb (,NYSE: BMY,), marking...

 Belite Bio's (NASDAQ: BLTE) Tinlarebant Granted Sakigake Designation for STGD1 Treatment

Belite Bio's (NASDAQ: BLTE) Tinlarebant Granted Sakigake Designation...

June 12, 2024 01:06 AM PDT | By Team Kalkine Media

Belite Bio, Inc (,NASDAQ: BLTE,), a distinguished player in the realm of clinical-stage biopharmaceutical drug development, has achieved a significant...

 Alvotech (NASDAQ: ALVO) and STADA Forge Strategic Alliance to Expand Access to Biosimilars

Alvotech (NASDAQ: ALVO) and STADA Forge Strategic Alliance to Expand...

June 11, 2024 01:29 AM PDT | By Team Kalkine Media

Alvotech (,NASDAQ: ALVO,) and STADA, two prominent players in the pharmaceutical industry, have announced the extension of their strategic alliance, a...

Recent Articles

 Mpeppe, Poodlana offer high returns through DeFi features and community engagement
July 24, 2024 06:39 AM AEST | By Invezz

 Gulf stock markets surge: Dubai leads with earnings boost as Fed rate cut speculation mounts
July 24, 2024 06:28 AM AEST | By Invezz

 Best energy ETF for a Trump presidency: Will XLE shine amidst pro-oil policies?
July 24, 2024 05:51 AM AEST | By Invezz

 The hidden divide: How wealth disparity is shaping the US economy
July 24, 2024 04:47 AM AEST | By Invezz

 Texas Instruments faces investor scrutiny amid high capex spending: What to expect in Q2 earnings
July 24, 2024 04:37 AM AEST | By Invezz